Larvol Delta - A-Study-to-Evaluate-Efficacy-and-Safety-of-Intravenous-Sabirnetug-in-Participants-with-Early-Alzheimer39s-Disease-ALTITUDEAD

sabirnetug IV (ACU193 IV) - Acumen Pharma

http://clinicaltrials.gov/ct2/show/NCT06335173

Oct 2, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next